SuperDave, you point out some of the peculiarities of this company. If you disclose anything goes on the OTC. It is very evident that the CEO,if that's what you call the only person in charge, has been able to enrich himself at new investors expense. Not only in perks and medical benefits, but a cut of newly raised funds as well.